Replies to post #9946 on Organovo Holdings, Inc. (ONVO)

[RandolRocketman]

There have already been concerted, illegal efforts to squash this company by short and distort attacks. Which have also failed. All it did was allow some of us to acquire more shares at stupid cheap prices like we have here now.
But what you say is true. There is a chance that some big pharma could feel threatened and try some underhanded methods to squash this technology. Unfortunately, Uncle Sam originally funded the research into Organovo's bioprinting technology, and has the rights to all the IP. Therefor, it's inevitable that we will have 3D bio printed replacement organs available to us, and at this point, the only means left for big pharma is to get on board and try to capitalize is by partnering in the upcoming clinical studies. Those who are not friends with Organovo will be left with old obsolete tech like pills and potions, and will eventually become irrelevant.

[RandolRocketman]

By the way, if ONVO's TOX testing is far and away a more superior method of ensuring a drug will pass human clinical trials, which all evidence points to that being the case, then the future success or failure of Organovo is likely of far lessor concern to some big pharma, than what would be saving billions right now by preventing a failed clinical trial, by using this superior testing method.
Let big pharma keep their short sighted time horizon, as ONVO moves ever closer to their stated goal of creating replacement tissue for human transplant without the need for rejection meds.